Outcome of Board Meeting held on 30.04.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Samsrita Labs Limited met on 30.04.2025 and approved several key items. First, the authorised share capital will be increased from Rs. 16 crore (1.6 crore equity shares of Rs. 10 each) to Rs. 25 crore (2.5 crore equity shares of Rs. 10 each), subject to shareholder approval. Second, the company will issue 38,40,000 equity shares to 26 non-promoter investors on a preferential basis at Rs. 10 per share. Third, Samsrita Labs will acquire a 28.62% stake in Qrops Advisory Services Private Limited (turnover of Rs. 22.26 crore in FY25) through a share swap, issuing up to 45,50,004 equity shares at a 1:3 swap ratio, valued at Rs. 4.55 crore. Fourth, the main objects of the company will be amended to include biofuels, food processing, green technology, IT, logistics, e-commerce, clinical research, and advisory services. An Extra Ordinary General Meeting is scheduled for 23rd May 2025 to seek shareholder approval.
Post the preferential allotment and swap, promoters' holding will drop to 31.45% while public holding will rise to 68.55%, leading to significant dilution for existing shareholders. The acquisition and expansion of business objects signal a strategic pivot into consulting, IT, and new-age sectors, which may reshape the company's long-term growth trajectory.